Open access

YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/β‐Catenin Signaling Pathway via Targeting NEK7

Xiaoran Sun Yi-Fan Chen Kun-Yi Liu Yi Si Mingda Xuan Rui Zhang Jiao Jiao Ting Liu Shuang-Shuang Han Jia Wang Wei-Fang Yu

Jul 2026 · Journal of Gastroenterology and Hepatology · Vol 41, pp. 2761 - 2779 · 0 citations · 35 references

Medicine

TL;DR

This study aimed to investigate the biological function, clinical significance, and underlying molecular mechanism of the RNA‐binding protein YTHDF3 in gastric cancer (GC) progression.

Abstract

Gastric cancer remains a major global health burden. This study aimed to investigate the biological function, clinical significance, and underlying molecular mechanism of the RNA‐binding protein YTHDF3 in gastric cancer (GC) progression.

DOI PubMed Semantic Scholar

Read PDF

Similar papers

Open access Aug 2026

miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway [Retraction]

[This retracts the article DOI: 10.2147/OTT.S171043.].

Chuansheng Li, Jing-Wei Zhang, Zhong-Liang Ma et al. · OncoTargets and Therapy · 0 citations

Open access Aug 2026

PCAT6 Regulates IGF2BP1/PD‐L1 to Promote Immune Escape in Breast Cancer

This study aims to elucidate the mechanism through which prostate cancer‐associated transcript 6 (PCAT6) modulates immune escape in triple‐negative breast cancer (TNBC), focusing on its interaction with IGF2BP1 and PD‐L1.

Dingping Sun, Shanglong Sun, Jing Li et al. · Journal of Gene Medicine · 0 citations

Open access Aug 2026

CCT2 Promotes Immune Escape in Colorectal Cancer by Regulating the JAK1‐STAT3‐PD‐L1 Axis

This study explored the molecular mechanisms underlying CRC immune evasion as well as the therapeutic effects of immune checkpoint inhibitors in microsatellite‐stable/proficient mismatch repair CRC.

Li-Qiang Gu, Shao-Fei Li, Yi-Chao Tang et al. · Journal of Gastroenterology... · 0 citations

Open access Aug 2026

[Corrigendum] MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A

[This corrects the article DOI: 10.3892/ol.2016.5423.].

Lu-Min Wang, Jia-Yi Yao, Hong-Fei Sun et al. · Oncology Letters · 0 citations

Open access Aug 2026

ANXA1/FPR Signaling Contribute to Paclitaxel Resistance in Ovarian Cancer Through PI3K/AKT‐Associated PGC1α Regulation

Ovarian cancer has the highest mortality among gynecologic malignancies, and acquired resistance to paclitaxel severely limits its clinical efficacy.

Li Zhou, Ming-Hao Jiang, Yue-Yang Zhou et al. · Cancer Reports · 0 citations

Open access May 2026

Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signaling

Hepatocellular carcinoma (HCC), a leading cause of cancer death, has a dynamic and heterogeneous tumor microenvironment (TME) that drives progression and therapeutic resistance. We previously elucidated that apoptosis antagonizing transcription factor (AATF) drives angiogenesis in HCC. However, its role in TME remains...

Diwakar Suresh, Akshatha N. Srinivas, Bharathwaaj Gunaseelan et al. · bioRxiv · 0 citations